Humana Inc vs Quanta Services Inc — how do they compare? Humana Inc trades at $442 (market cap $47.61B), while Quanta Services Inc trades at $690.88 (market cap $105.40B). The key difference: Quanta Services Inc is far larger — about 2.2× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Quanta Services Inc for 62 Days on average.
| HUM | PWR | |
|---|---|---|
Market Cap | $47.61B | $105.40B |
Volume | 1,827,332 | 1,014,408 |
Sector | Health | Industrials |
52-Week High | $409.85 | $785.24 |
52-Week Low | $163.67 | $412.21 |
Typical Hold Time | 53 Days | 62 Days |
Enterprise Value | $54.97B | $111.50B |
Dividend Yield | 0.89% | 0.06% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Quanta Services (PWR) trades at $685.33, down 4.76% on the day, but maintains a bullish technical trend with strong analyst support. Revenue growth is robust, climbing from $17.1B in 2022 to $28.5B in 2025, with net income reaching $1.03B. The company benefits from a record $53B backlog and positive earnings surprises, though valuation multiples like a P/E of 80.21 suggest premium pricing. Recent news highlights PWR's role in AI infrastructure and data center spending, driving investor optimism.
Outlook remains positive given strong earnings beats and sector tailwinds, but high valuation and execution risks from rapid expansion pose challenges. Analysts see 26.5% upside to a $802.08 consensus target, with no sell ratings. Risks include margin pressure and macroeconomic sensitivity, yet institutional bullishness and operational momentum support long-term growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →